ConductScience.org, home

Gene · 4065

NIH grants1,428

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleLY75 papersNewest fiscal year
P30CA091842Cancer Center Support Grant22025
P30DK020572Michigan Diabetes Research Center (MDRC)22025
P30DK020579Diabetes Research Center22025
P30DK026743UCSF Liver Center22025
P30DK042086Center for Interdisciplinary Study of Inflammatory Intestinal DIsorders (C-IID)22025
P30DK043351Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital22025
P30DK116073University of Colorado Anschutz Medical Campus DRC22025
P41EB028239The Johns Hopkins Translational ImmunoEngineering (JH-TIE)22025
R01AI121066Innate control of the inflammatory process during fungal infections22025
R01AI158808Transitional dendritic cells: identifying the origin and role of a novel innate immune population during viral infection22025
R01CA149456Targeting PD-L1 interactome signaling to enhance immunotherapy efficacy in head and neck squamous cell cancer22025
R01CA155010Personal tumor neoantigens for immunity against chronic lymphocytic leukemia22025
R01DK069861Restoring Central Regulation of Glucose Production in Type 2 Diabetes22025
R01DK115217Type III interferon Control of Mucosal Immunity22025
R01GM086868Structure, Function and Applications of Inteins22025
R01HL086694From GWAS loci to blood pressure genes, variants & mechanisms - Renewal22025
T32AI007090Interdisciplinary Training Program in Immunology22025
T32AI007405Training Program in Immunology22025
T32CA009676Training Program in Tumor Microenvironment22025
T32DK120520Interdisciplinary Bioengineering Research Training in Diabetes22025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/4065/grants?page=2